Posted by ABMN Staff on Apr 28th, 2024
CME Group (NASDAQ:CME – Free Report) had its price objective increased by Bank of America from $209.00 to $216.00 in a research note published on Thursday, Benzinga reports. Bank of America currently has a neutral rating on the...
More of this article »